×
About 118 results

ALLMedicine™ Aids Dementia Complex Center

Research & Reviews  33 results

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
https://clinicaltrials.gov/ct2/show/NCT00000738

Nov 4th, 2021 - HIV-infected patients may develop a condition known as HIV-Associated Motor / Cognitive Complex (also known as AIDS dementia complex) that causes damage to the nervous system, particularly the brain and spinal cord. Evidence exists that nimodipine...

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
https://clinicaltrials.gov/ct2/show/NCT00000657

Nov 3rd, 2021 - HIV-infected or AIDS patients may develop ADC which causes damage to the nervous system. ADC may be caused by some action of the AIDS virus on the nervous system, although similar problems can be caused by other infections because the AIDS virus l...

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infec...
https://clinicaltrials.gov/ct2/show/NCT00000702

Nov 3rd, 2021 - HIV infection can result in impairment in the function of the brain and spinal cord, leading to disturbances in the ability to think clearly and in strength and coordination. This disorder, which has been called the AIDS dementia complex, may be d...

An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
https://clinicaltrials.gov/ct2/show/NCT00000709

Oct 29th, 2021 - Individuals with AIDS frequently suffer central nervous system (CNS) problems that are characterized by cognitive, motor, and behavioral deficits, in a disorder known as AIDS dementia complex. Clinical experience suggests that its course is often ...

Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients
https://clinicaltrials.gov/ct2/show/NCT02276326

Jun 28th, 2018 - The HIV virus has a marked tropism for the central nervous system. In 1986, the term AIDS Dementia Complex (ADC) has been coined which includes in a single syndrome, a whole series of severe neurologic manifestations, characterized by cognitive, m...

see more →

Clinicaltrials.gov  10 results

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
https://clinicaltrials.gov/ct2/show/NCT00000738

Nov 4th, 2021 - HIV-infected patients may develop a condition known as HIV-Associated Motor / Cognitive Complex (also known as AIDS dementia complex) that causes damage to the nervous system, particularly the brain and spinal cord. Evidence exists that nimodipine...

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infec...
https://clinicaltrials.gov/ct2/show/NCT00000702

Nov 3rd, 2021 - HIV infection can result in impairment in the function of the brain and spinal cord, leading to disturbances in the ability to think clearly and in strength and coordination. This disorder, which has been called the AIDS dementia complex, may be d...

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
https://clinicaltrials.gov/ct2/show/NCT00000657

Nov 3rd, 2021 - HIV-infected or AIDS patients may develop ADC which causes damage to the nervous system. ADC may be caused by some action of the AIDS virus on the nervous system, although similar problems can be caused by other infections because the AIDS virus l...

An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
https://clinicaltrials.gov/ct2/show/NCT00000709

Oct 29th, 2021 - Individuals with AIDS frequently suffer central nervous system (CNS) problems that are characterized by cognitive, motor, and behavioral deficits, in a disorder known as AIDS dementia complex. Clinical experience suggests that its course is often ...

Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients
https://clinicaltrials.gov/ct2/show/NCT02276326

Jun 28th, 2018 - The HIV virus has a marked tropism for the central nervous system. In 1986, the term AIDS Dementia Complex (ADC) has been coined which includes in a single syndrome, a whole series of severe neurologic manifestations, characterized by cognitive, m...

see more →

News  4 results

Confusion in a Patient With HIV
https://www.medscape.com/viewarticle/505635_1

Jun 2nd, 2005 - Summary 47 year-old male with HIV presents with confusion. (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) What is the LEAST likely diagnosis? AIDS dementia complex Lymphoma Progressive multifocal leukoencephalopath...

Confusion in a Patient With HIV
https://www.medscape.com/viewarticle/505635

Jun 2nd, 2005 - Summary 47 year-old male with HIV presents with confusion. (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) (Enlarge Image) What is the LEAST likely diagnosis? AIDS dementia complex Lymphoma Progressive multifocal leukoencephalopath...

Brain Injury Seen in HIV Patients on HAART
https://www.mdedge.com/internalmedicine/article/14680/infectious-diseases/brain-injury-seen-hiv-patients-haart
Diana Mahoney

MONTREAL — Evidence of significant brain inflammation and neuronal damage in patients with clinically stable HIV infection suggests that central nervous system injury persists despite successful viral control, Dr. Bradford Navia reported at the Co.

Nonopportunistic Neurologic Manifestations of the Human Immunodeficiency Virus: An Indian Study
https://www.medscape.com/viewarticle/511865

Abstract HIV-1 is a neurotropic virus. In a resource-limited country such as India, large populations of affected patients now have access to adequate chemoprophylaxis for opportunistic infections (OIs), allowing them to live longer. Unfortunately...

see more →